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Restenosls: Molecular Mechanisms
Conclusion: High direct cost patients can be identified prior to a CABG. Al-
though these variables themselves are not directly amenable to modification.
proactive intervention through general case management may decrease the
total costs of the procedure and allow more efficient allocation of resources.
In addition. these data can be directly employed to adjust contract pricing
for case-rnix.
1988 1993
Order standardization
Tests per patients 56.3 419
Charge patient 2866 2062
1993 saving $1,163.488
Same day extubation 1% 50%
Reintubation 0.7% 0%
First day ICU transfer 2% 62%
Six day hospital stay 4.6% 50%
Charges (normalized 1993 dollars)
106 $46,311 $37,615
107 $34,638 $29,545
Mortality 106/107 3.2 2.7
Number cases 861 795
Peripheral vascular disease
Non·private patient
Widow{er)
Non-use ITA
$6.381
$5,283
$4.908
$4.842
Age (cost per decade)
CHF NYHA class
Angina CHA class
Symptomatic
$1,950
$293
$195
$88
Systems analysis approach may have a significant impact on resource con-
sumption, changes and length of stay in a clinical setting. Wednesday, March 22,1995,4:00 p.m.-5:00 p.m.
Ernest N. Morial Convention Center, Room 9
Nowa Omoigui, John Elliott, John Allen, Kim Brown, Mark Hanson,
Kingsley Annan, Brian Griffin, Patrick Whitlow, Murat Tuzcu. The Cleveland Clinic
Foundation. Cleveland. OH
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Osteonectin and Osteocalcin mRNA are Expressed in
Human Atherosclerotic Lesions and Upregulated
Following Balloon Angioplasty
Correlates of IMV cost in multivariable stepwise regression analysis were:
93.5% of IMV were successful without valve surgery. Median costs lin
1993 dollars) using the Transition Systems Inc. accounting method. and
length of stay (LOS) were higher for OMV than IMV (p < 0.001). Deaths and
Strokes were similar:
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Histological and Molecular Biological Characteristics
of Restenotic Sapheneous Vein Grafts
Post-Angioplasty
Sanjay Srivasta. Robert Schwartz, William Edwards. Lorraine Fitzpatrick. Mayo
Clinic. Rochester, MN
Matrix proteins such as osteonectin and osteocalcin play an active role in
mineralization. cell adhesion and migration. Osteocalcin is chemoattractive
for monocytes and mesenchymal cells; its synthesis is vitamin K-dependent
and it is associated with mineralization. Osteonectin binds to calcium and is
abundant in platelets and remodeling tissue. We studied the expression of
ON and OC mRNA in coronary arteries obtained at autopsy in patients who
underwent balloon angioplasty (PTCA). Primary atherosclerotic and PTCA
sections were hybridized with 35S-labelled oligonucleotides derived from
sense and antisense sequences. Sense controls were negative and signal
was rarely detected in segments without atherosclerosis. In arteries that
had PTCA performed. abundant signal was found in the organizing throm-
bus and in the adventitia. with increased abundance of mRNA detected over
time after PTCA. In uninjured segments of atherosclerotic artery, OC and ON
were detected in the plaque and extensively throughout the adventitia and
associated with calcified areas. We suggest: 11 Expression of OC and ON
mRNA occurs in human atherosclerotic arteries and is associated with cal-
cification; 2) OC and ON mRNA expression is not confined to plaque and is
present extensively in the adventitia; 3) Following PTCA, upregulation of OC
and ON mRNA in the adventitia may regulate the reparative and remodeling
response to vascular injury.
Sigrid Nikol 1,2, Peter Gonschior 1. Lawrence Weir 2, Jeffrey Isner 2.
Berthold Hofling. 1Ludwig-Maximilians-Universitat Munchen. Germany: 2Tufts
University. Boston, MA
Vascular repair of vein grafts following angioplasty appears to be differ-
ent from arterial vascular repair. This prompted us to investigate atherec-
tomy specimens of patients who had undergone CABG surgery and under-
went one or more angioplasties in a vein graft at the same site. for his-
tology and TGF-p1 gene expression. 11 atherectomy specimens, 7 of pa-
tients with single and 4 of patients with multiple restenosis events were
investigated. The mean time interval from the last restenosis event was
7,3 ± 5.2 months. Immunohistochemistry was performed using antibodies
against a-actin, desmin. collagen I and IV, macrophages, monocyte-derived
macrophages. endothelial structures and proliferation markers. In situ hy-
bridization using a specific cDNA probe for TGF-pl was performed and sil-
ver grains over nuclei and arbitrarily defined areas. indicating TGF-p1 expres-
sion. were counted. In adjacent sections cell density and areas containing
extracellular neo-matrix were measured. Restenosis tissues compared with
primary lesions showed a higher incidence of cellular components (70% vs
10%) and a lower macrophage content 120% vs 43%). Myocytes of vary-
ing phenotypes were seen in restenosis tissues, mainly meeting the criteria
for "myofibroblasts". The area of extracellular neo-rnatrix correlated with the
time interval of restenosis (r = 0.63). and both TGF-p 1 expression and extra-
cellular neo-matrix formation inversely correlated with cell density (r = 0,81
and r = 0.69. respectively). TGF-p 1expression was greater in lesions that had
multiple restenotic events (15.1 ± 6.1 vs 5.6 ± 5.1 grains/nucleus. p < 0.05).
Conclusion: Histological features of restenotic sapheneous vein grafts post-
angioplasty are high cellularity. high "rnyofibroblast" and low macrophage
Valve area (mean)
1.1 cm 2
1.1 cm 2
Cost ($)
5,210
19,692
p = 0.0001
P = 00035
p~00263
Echo score (mean)
7.1 ± 15
77 ± 25
LOS (days)
Female
87.0%
94.7%
0.0%
0.0%
StrokeDeath
2.2%
5.3%
51.4 ± 12.01
53.6 ± 12.9
Age (mean)
IMV
OMV
IMV
OMV
Mitral valve replacement
Hospital delay >24 hours prior to IMV
Final trans-mitral gradient
What Price CABG? Individual Patient
Characteristics that Influence Direct Costs
Timothy A. Denton. George A. Diamond, Jack M. Matloff, Cedars-Sinai Medical
Center, Los Angeles, California
Between January 1992 and December 1993, 46 Inoue Mitral Commissuro-
tomies (IMV) were performed as part of a Multicenter Investigation. In the
same period. 19 IMV-eligible open mitral valvuloplasties (OMV) were per-
formed for mitral stenosis. There were no differences in baseline character-
istics (p = NS):
After controlling for LOS, intra-procedural transesophageal echocardiog-
raphy predicted higher cost (p = 0.006).
In conclusion. IMV is an effective short-stay cost minimizing strategy in ap-
propriate patients. Cost savings can be obtained by expeditiously achieving
a low residual gradient while avoiding mitral valve replacement. The cost-
benefit of routine transesophageal echocardiography requires further study.
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There are two methods to control procedural costs: (1) make systematic
changes that reduce costs on all patients. and (2) identify potentially high
cost patients and proactively intervene to keep costs low in those individ-
uals. To determine which patient characteristics are predictive of high cost.
we studied a series of 722 consecutive patients (3/12/90 to 3/22/94) undergo-
ing routine CABG (DRG 107 - CABG without catheterization) to determine
which individual characteristics contributed to direct costs.
Using the Cedars-Sinai Cardiothoracic Surgery database. we identified 31
prospectively collected candidate variables from the preoperative and oper-
ative periods which might contribute to the overall direct costs of bypass.
Total direct costs were obtained from the hospital central financial system
for each patient. Only patients who survived to discharge were included in
the analysis. Forward, stepwise. multiple linear regression was used to de-
termine which candidate variables contributed to total direct costs.
Of the 31 candidate variables. 3 demographic (age, non-private patient.
widow(er)). 4 preoperative clinical (presence of symptoms. angina CHA
class. CHF NYHA class. peripheral vascular disease). and 1 intraoperative
variable (non-use of the internal thoracic artery - ITA) contributed to the
cost of CABG (p < 0,04), The following table presents each characteristic
and the incremental associated cost of that characteristic:
